Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy

In these contemporary data from 31 245 patients who are receiving statin therapy, residual inflammatory risk appears to be more strongly associated with future cardiovascular events than residual cholesterol risk.

Read the full Article